Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ScreenPoint Medical logo — The Breast AI Company: Leading the way in early breast cance...

ScreenPoint Medical

The Breast AI Company: Leading the way in early breast cancer detection.

Founded 2014 The Netherlands The Netherlands 86 employees Series C Total: $46.80M AI, Analytics +1

General Information

Company Name ScreenPoint Medical
Founded Year 2014
Location The Netherlands The Netherlands
Employees 86
Industries AI, Analytics, Machine Learning
Funding Stage Series C
Business Model B2B, SaaS
Revenue Model Subscription, Licensing, Usage Based
Offices as of Sep 2026
Nijmegen, The Netherlands
Social

BounceWatch is an independent company data service, not affiliated with ScreenPoint Medical. To contact ScreenPoint Medical, visit screenpoint-medical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Growth Metrics Sep 30, 2026

ScreenPoint Medical's Transpara® AI is featured for screen-reading across 122,969 examinations, indicating a growing evidence base.

Major Customer Win Sep 25, 2026

ScreenPoint Medical expresses gratitude to Dr. Barbara Valenti for sharing how Transpara fits into her real-world workflow.

Event Participation Sep 22, 2026

ScreenPoint Medical attended the R3 Imaging 2026 event on Lake Constance, where they engaged with breast radiologists about AI in imaging.

Actively Hiring Sep 04, 2026

Hiring for 3 positions in the last 30 days.

Get alerts when ScreenPoint Medical shows new signals

About ScreenPoint Medical

ScreenPoint Medical, founded in 2014 and based in The Netherlands, defines itself as The Breast AI Company, leading the way in early breast cancer detection. Their slogan emphasizes their commitment: "The Breast AI Company: Leading the way in early breast cancer detection."

The firm specializes in AI, Analytics, and Machine Learning to enhance breast radiology with precision through its proprietary Transpara algorithms. ScreenPoint Medical is notably committed to applying their technology for impactful real-world outcomes, aiming to redefine breast imaging standards and provide personalized care pathways for every woman.

The company garnered a $14.00M grant investment on 01 April 2026, led by prominent investors Insight Partners and Siemens Healthineers. This financial backing evidences confidence from major industry players, positioning ScreenPoint Medical as a noteworthy contender in the AI-powered medical technology landscape.

Taxonomy: AI-powered technology, Breast cancer detection, Breast radiology, Personalized care pathways, Deep Learning, Image analysis, Mammogram reading, Digital breast tomosynthesis, Computer-aided detection (CAD), Medical imaging, Decision support, Machine learning, Clinical deployment, Breast health solutions, Automated mammogram analysis

Services & Products

Transpara Breast AI
Breast Cancer Detection
Breast Density Analysis
AI-enhanced Imaging Workflow
Temporal Comparison in Mammography

Target Customers

Radiologists Breast Imaging Centers Hospitals and Clinics Health Systems Screening Programs

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $14.00M 2
Insight Partners Siemens Healthineers
Insight Partners, Siemens Healthineers
01 Apr 2026
Series C $28.00M 4
Insight Partners Oost NL Siemens Healthineers
Insight Partners, Oost NL +2
01 Jul 2021
Series B €4.30M 1
Siemens
01 Jun 2018
Grant €500.00K -
01 Oct 2015
Spinout Undisclosed 1
University Ventures
University Ventures
01 Jan 2014

Latest News

View All
Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding — Eu-startups
Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding
Eu-startups Jul 06, 2026
Insight Partners-backed ScreenPoint Medical secures €13.6 million to advance AI-powered breast cance... — Eu-startups
Insight Partners-backed ScreenPoint Medical secures €13.6 million to advance AI-powered breast cancer detection
Eu-startups Apr 20, 2026

ScreenPoint Medical Alternatives & Competitors

View All Alternatives
ScreenPoint Medical vs
contextflow
contextflow Austria

Supporting physicians in the diagnosis of lung conditions with comprehensive structural + functional...

Series A
31 employees
AI, Big Data
ScreenPoint Medical vs
Lunit Cancer Screening
Lunit Cancer Screening United States

Lunit is a public company that develops medical AI software that helps conquer cancer globally.

Post-IPO Debt
343 employees
AI, Analytics
ScreenPoint Medical vs
b-rayZ
b-rayZ Switzerland

Empower Mammography through Artificial Intelligence

Series A
20 employees
AI, Analytics
View all alternatives

FAQ About ScreenPoint Medical

The Breast AI Company: Leading the way in early breast cancer detection.
ScreenPoint Medical was founded in 2014.
ScreenPoint Medical is headquartered in The Netherlands. As of Sep 2026, it also has offices in Nijmegen, The Netherlands.
ScreenPoint Medical operates in AI, Analytics and Machine Learning. Its work centres on AI-powered technology, Breast cancer detection, Breast radiology and Personalized care pathways. Its customers include Radiologists, Breast Imaging Centers and Hospitals and Clinics.
ScreenPoint Medical has a B2B and SaaS business model. Its revenue comes from Subscription, Licensing and Usage Based.
ScreenPoint Medical has approximately 86 employees.
ScreenPoint Medical has completed 5 funding rounds, raising a total of $46.80M. The latest funding stage is Series C.
ScreenPoint Medical offers: Transpara Breast AI, Breast Cancer Detection, Breast Density Analysis, AI-enhanced Imaging Workflow, Temporal Comparison in Mammography.
Top alternatives and competitors to ScreenPoint Medical include contextflow, Lunit Cancer Screening, b-rayZ, Viz.ai, Envisionit Deep AI®. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ScreenPoint Medical and contextflow are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ScreenPoint Medical, https://bouncewatch.com/company/screenpoint-medical, updated 31 August 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes